Net loss widened to -2,551 KSEK with no revenues, but cash position improved after a 13.2 MSEK rights issue. Focus remains on commercializing methane-to-hydrogen technology, supported by EU funding and new permit applications.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.